Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Signs On University of Tuebingen Institute as MassArray User

NEW YORK, Aug. 17 (GenomeWeb News) – Sequenom has signed on the University of Tuebingen in Germany as a user of its MassArray gene expression platform, the company said today.

Under the agreement, the Institute of Medical Genetics and the Microarray facility at the university will use the MassArray Quantitative Gene Expression application to validate existing microarray data and for additional research in Parkinson’s disease, Huntington’s disease and cancers.

The institute will also be a reference site for the system, Sequenom said.

The parties did not disclose the financial terms of the agreement.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.